seed
Stage
2
Investors
About
HookeBio develops microfluidic technology platforms for high-throughput combinatorial drug screening, enabling automated and miniaturized testing of compound combinations for drug discovery.
Explore HookeBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.